Benzamide, N-cyclopropyl-4-[8-[(2-methylpropyl)amino]imidazo[1,2-a]pyrazin-3-yl]- manufacturers
- Mps-BAY2b
-
- $2500.00
-
2026-05-11
- CAS:1263420-68-3
- Purity:
- Supply Ability: 10g
|
| | Benzamide, N-cyclopropyl-4-[8-[(2-methylpropyl)amino]imidazo[1,2-a]pyrazin-3-yl]- Basic information |
| | Benzamide, N-cyclopropyl-4-[8-[(2-methylpropyl)amino]imidazo[1,2-a]pyrazin-3-yl]- Chemical Properties |
| density | 1.31±0.1 g/cm3(Predicted) | | pka | 14.34±0.20(Predicted) |
| | Benzamide, N-cyclopropyl-4-[8-[(2-methylpropyl)amino]imidazo[1,2-a]pyrazin-3-yl]- Usage And Synthesis |
| Description | Mps-BAY2b is a novel inhibitor of MPS1. | | Uses | Mps-BAY2b is a oral active monopolar spindle 1 (MPS1) inhibitor with the IC50 of 14 nM (human MPS1). Mps-BAY2b shows anticancer activity and can be used for study of cancer[1]. | | References | [1] Jemaà M, et al. Characterization of novel MPS1 inhibitors with preclinical anticancer activity. Cell Death Differ. 2013 Nov;20(11):1532-45. DOI:10.1038/cdd.2013.105 |
| | Benzamide, N-cyclopropyl-4-[8-[(2-methylpropyl)amino]imidazo[1,2-a]pyrazin-3-yl]- Preparation Products And Raw materials |
|